Future Positive Capital

www.futurepositivecapital.com

VCMatch tracks Future Positive Capital as an investor focused on Healthtech, Medtech, and Biotech companies, Seed and Series A rounds, Belgium, France, and Germany markets, and $500k to $3m check sizes. Upload your deck to compare your startup against the full private matching profile.

Check Size

$500k to $3m

Stages

Seed, Series A

Focus Areas

Healthtech, Medtech, Biotech

Geography

Belgium, France, and Germany

Investment Thesis

Future Positive Capital invests in European companies that drive innovation to solve universal challenges on a planetary scale. They believe value is created through a holistic combination of business, technological innovation, societal/environmental, and human factors that mutually reinforce each other. Their investment thesis is rooted in the conviction that “Companies that build futures we aspire to live in will define our time” and that the scale and urgency of global challenges is now matched by entrepreneurs’ capacity to build step-change solutions.

Is Future Positive Capital right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Future Positive Capital is most relevant for founders raising Seed and Series A rounds in Healthtech, Medtech, Biotech, and Climate/Cleantech, especially across Belgium, France, and Germany, with public check-size signals around $500k to $3m.

Focus statement

We invest in European companies that drive innovation to solve universal challenges on a planetary scale. We partner with entrepreneurs to cultivate holistic value – where the benefits of economic, human, societal and technological value compound to unlock unlimited potential.

Value Add

Problems-first approach: they only invest in what they deeply understand after multi-year deep dives into challenge areas
Holistic value creation framework integrating business, innovation, societal, and human value simultaneously
100% of carried interest indexed to both financial AND impact performance of portfolio companies
Concentrated approach as a boutique firm that leads or co-leads rounds with conviction
Early movers in the space with years of backing universal challenge companies before mainstream adoption
Long-term patient capital aligned with founder vision and values rather than financial returns alone